Publikationen – Maiwald

17 Oct 2024 -

Test publication with author CN

22 Aug 2024 -

Test Publikation zur Verbindung CN

7 Dec 2023 -

Maiwald makes the case for patent lawyers to learn something new: LiquidText, The Patent Lawyer (Annual 2024)

The Patent Lawyer Editorial Board looks back at 2023 to summarize key cases and developments by jurisdiction. Influenced by several years of use,

7 Dec 2023 -

Repeated trademark filings: EUIPO Board addresses ‘annoying’ practice, Managing IP 2023

In a recent article with the title "Repeated trademark filings: EUIPO Board addresses 'annoying' practice" published by Managing IP,

17 Oct 2023 -

The springboard doctrine in the context of patent law – part two, Managing IP 2023

In concluding a two-part series on springboard injunctions, Dr Marco Stief takes a deeper dive to explai...

4 Oct 2023 -

The springboard doctrine in the context of patent law – part one, Managing IP 2023

In the first of two articles on the springboard doctrine, Dr Marco Stief explains how the protective effect of a pat...

31 Aug 2023 -

European Unitary Patent Package: Introduction to the New System including Strategic Considerations, (September 2023) 133 Intellectual Property Forum 40

The creation of the unitary patent and the Unified Patent Court (“UPC”) heralds the beginning of a new era in patent law in Europe. The Agreement on a Unified Patent Court (“UPCA”) entered into force on 1 June 2023 when the new UPC finally began operations. The openi...

17 Aug 2023 -

European Commission proposes transferable data exclusivity vouchers to tackle the antimicrobial resistance crisis, Managing IP 2023

In a recent article published by Managing IP, Dr Marco Stief considers a regulatory proposal designed to promote an...

31 Jul 2023 -

Ergänzende Schutzzertifikate für Arzneimittel, EuZW 2023, 643

On April 27, 2023, the European Commission presented four proposals for Regulations on supplementary protection certificates as part of the Intellectual Property Action Plan. In this article, Dr Gisela Gr...

30 Jun 2023 -

Ersatzansprüche bei ungerechtfertigten einstweiligen Verfügungen im Pharmabereich – Ansprüche des Antragsgegners und geschädigter Dritter, GRUR 13/2023

Preliminary injunctions orders are commonly granted for pharmaceutical patents. If an order later proves to be unfounded, under § 945 German Code of Civil Procedure (ZPO) the defendant generic company can claim damages on the basis of the plaintiff's strict liability. Howev...

22 Jun 2023 -

A path towards a crisis-proof EU pharmaceutical legislation? The European Commission proposal, MIP 2023

On April 27 2023, the European Commission presented a proposal for the reform of the general pharmaceutical legislation in the EU. The proposal is based on

5 Jun 2023 -

Quo vadis Arzneimittelrecht – ein Überblick zur Überarbeitung der EU-Arzneimittelvorschriften, PharmR 6/2023

On April 27, 2023, the EU Commission presented a proposal for the reform of the pharmaceutical legislation in the EU. The proposal would lead to broad and far-reaching changes to the Regulation and the Directive, providing, for example for variable protection periods (standa...

16 May 2023 -

Der texanische “Two-Step”- Umstrittene juristische Strategie zur Begrenzung der Unternehmenshaftung, Arzneimittel & Recht 2/23

by Dr Marco Stief Since 1989, it has been possible under Texas law to divide a business corporation into individual entities by way of a so-called "d...

25 Apr 2023 -

Decision on cease-and-desist declarations according to the ‘Hamburg custom’, MIP 2023

In its judgment of December 1 2022 (Case No. I ZR 144/21), the German Federal Court of Justice (FCJ) clarified several important points, which Dr Christian Meyer discusses in more detail in his arti...

21 Mar 2023 -

The role of patent attorneys in patent infringement disputes in Germany and Europe, MIP 2023

In the article "The role of patent attorneys in patent infringement disputes in Germany and Europe", published by Managing IP, Dr-Ing. Bo-Hyun Lee considers how the Unified Patent Court will affect the ...

21 Mar 2023 -

Interview on the UPC in the magazine “Die Welt” – Smart Rechtsguide, 2023

In the issue (No. 57) of "die Welt", Dr.-Ing. Sophie Ertl answered questions about the UPC as part of the supplement "Smart Rechtsguide": "Unitary Patent and Unitary Patent Court - what you need to know...

20 Mar 2023 -

EuGH: Plattformbetreiber haften für Markenrechtsverletzungen durch Drittanbieter – der Fall Louboutin/Amazon, BetriebsBerater 12/2023

In the contribution in the 12/2023 issue of the BetriebsBerater journal, Dr Marco Stief reports on a ruling by the ECJ that significantly extends the liability of online platforms for third-party tradem...

20 Mar 2023 -

Focus on: Anmeldeverfahren und Anmeldungen “Nicht immer ohne unerwünschte Nebenwirkungen – Einwendungen Dritter im Prüfungsverfahren vor dem Europäischen Patentamt”, Legal500.de, 2023

Nicht immer ohne unerwünschte Nebenwirkungen – Einwendungen Dritter im Prüfungsverfahren vor dem Europäischen Patentamt: In seinem allgemeinen “Auftrags”-Statement verweist das Europäische Patent...

15 Mar 2023 -

Der patentrechtliche Verhältnismäßigkeitsgrundsatz im Bereich Arzneimittel und Medizinprodukte, Teil 2, PharmR 3/2023

With the Second Act on the Simplification and Modernization of Patent Law (2nd PatMoG), German patent law has undergone significant changes. In particular, in §139 (1) S.3 PatG a proportionality barrier with regard to the right to injunctive relief under patent law was codi...

1 Mar 2023 -

Pharmaceutical, Biological and Chemical Patents, C.H.BECK – 2023

by Prof. Dr Maximilian W. Haedicke, Dr Marco Stief and Dr Annelie Wünsche

28 Feb 2023 -

Louboutin v Amazon: direct liability of online platforms for third-party trademark infringement, MIP 2023

In a recent article, published by MIP, Dr Marco Stief reports on a ruling by the CJEU that significantly extends the liability of online platforms for third-party trademark infringement and explains what it means for online marketplaces and trademark owners.

27 Feb 2023 -

Die Einführung eines neuen Patentsystems in Europa, Betriebs-Berater 2023, Heft 09

by Dr Marco Stief It is official: On 17.2.2023 Germany has now also ratified the Agreement on a Unified Patent Court (UPC) and thus the start of the ...

15 Feb 2023 -

Der patentrechtliche Verhältnismäßigkeitsgrundsatz im Bereich Arzneimittel und Medizinprodukte, Teil 1, PharmR 2/2023

On August 17, 2021, the Second Patent Law Simplification and Modernization Act (2nd PatMoG) was proclaimed, resulting in several changes for patent law. In the article "Der patentrechtliche Verhältnismäßigkeitsgrundsatz im Bereich Arzneimittel und Medizinprodukte, Teil 1 ...

30 Jan 2023 -

No-challenge and pay-for-delay agreements in patent licence and settlement agreements under European competition law, Journal of Intellectual Property Law & Practice, Vol. 18/2, 02/2023, S.135–145

In the article "No-Challenge and Pay-for-delay Agreements in Patent License and Settlement Agreements under European Competition Law," recently published by the Journal of IP Law & Practice (Oxford University Press),

26 Jan 2023 -

Europe’s new Unitary Patent System will affect IP Agreements, Law360 2023

by Dr Marco Stief The introduction of the European patent and court system is causing significant upheaval and requires owners of European patents to...

17 Jan 2023 -

Die Reform der Gruppenfreistellungsverordnungen – FuE- und Spezialisierungs-GVO 2023, Wirtschaft und Wettbewerb 01/2023

by Dr Marco Stief with Dr Anna Giedke, Dipl. jur. Selina Stachowitz With effect from 1 January 2023, new versions of the R&D- and Specialisa...

10 Jan 2023 -

IP as a means of securing a loan under German law, Managing IP 2023

Intellectual property can be utilised commercially in many ways. In addition to the traditional forms – such as the granting of licences, selling, and the judicial enforcement of cease-and-desist orders and claims for damages – IP can also be used as collateral for loans...

23 Dec 2022 -

Interview IAM Strategy 300 Global Leaders, 2023

This year IAM has once again invited top IP strategists to tell readers more about their careers in intellectual property, top lessons learned along the way and their views on the current state of the market. Like IAM Global Leaders, which features top-ranked private practic...

12 Dec 2022 -

Proportionality defence v compulsory licence: the decision of the Düsseldorf court, Managing IP 2022

Dr Marco Stief of Maiwald explains a ruling by the Düsseldorf Regional Court in the matter NuCana v Gilead that establishes the subsidiarity of the objection o...

10 Nov 2022 -

IP Due Diligence und Pharma, |transkript 4-2022 im November – Spezial: “Patente / M&A / Lizenzierung”

Market leaders in the life sciences are interested in acquiring start-ups in order to acquire a new technology as soon as their investment risk can be better foreseen. In order to minimise the associated risks, a precise IP due diligence is required on the acquirer's side. I...

2 Nov 2022 -

JUVE Handbook 2022/2023: Co-publishing article on the topic of “Die Äquivalenz in der Patentverletzung: Neue Rechtsprechung”

In the current edition of the JUVE Handbook for Commercial Law Firms 2022/2023 published in October 2022 Dr Marco Stief,

24 Oct 2022 -

Preisanpassungsklauseln bei Verträgen zwischen Unternehmen, Betriebs-Berater 43/2022

In this article, Dr Marco Stief discusses the admissibility of value maintenance and price adjustment clauses in commercial contracts. After many ye...

19 Oct 2022 -

Einheitspatent und einheitliches Patentgericht – Vorstellung des neuen europaweiten Patent- und Gerichtssystems, PharmaR Heft 10/2022

In their contribution, Dr Marco Stief and

10 Oct 2022 -

ECJ ruling brings clarity on the interruption of forfeiture periods, Managing IP 2022

Susanna Heurung examines a decision by the European Court of Justice concerning the ending of a period of ‘acquiescence’ in a trademark case and what it means for potential plaintiffs

29 Sep 2022 -

Recent ECJ case law and latest referrals for preliminary rulings on the SPC Regulation, IAM 2022

by Dr Derk Vos The contribution highlights recent ECJ decisions regarding Article 3(a) of the SPC Regulation relating to one of the core aspects of SPCs...

19 Sep 2022 -

Germany cancels agreement with Switzerland on the use of trademarks, 2022

In the September edition of Managing Intellectual Property Susanna Heurung explains that owners of German trademarks who rely on their use in Switzerland mu...

16 Aug 2022 -

Ergänzende Schutzzertifikate – Überblick und Ausblick zur EU-Initiative, Arzneimittel & Recht, 2022

SPCs are currently based on Regulation (EC) No. 469/2009 on the supplementary protection certificate for medicinal products. Under a current EU initiative, the Commission is proposing, among other things, a single granting procedure and a single SPC system. In order to be ab...

28 Jul 2022 -

Do the experimental use and bolar exemptions also apply in contributory patent infringement cases? Journal of Intellectual Property Law and Practice, 2022

The reach of Sec. 10(3) of the German Patent Act (GPA) has been the subject of debate by German patent courts for many years. Final clarification by the German Supreme Court is still awaited on the extent to which third parties are liable for their own supplying acts which d...

12 Jul 2022 -

The biggest change is the introduction of a right to compensation under unfair competition law for consumers, 07/2022

In the Special Report of Leaders League, Dr Christian Meyer explains how the new claim for compensation, based on the Directive (EU) 2019/2161 of 27 Novembe...

11 Jul 2022 -

Patents: New principles in preliminary injunction proceedings, 2022

In the July edition of Managing Intellectual Property Heike Röder-Hitschke discusses a significant European Court of Justice (CJEU) ruling, and how it will affect future practice in preliminar...

28 Jun 2022 -

EU-Initiative zu Zwangslizenzen – Chance oder Wettbewerbsnachteil? Arzneimittel & Recht, 2022

In an article just recently published in the journal Arzneimittel & Recht (Edition 03/22) Dr Gisela Grabow and Dr Marc...

23 Jun 2022 -

Originator vs. Generics – Pharmaceutical patents in the context of PI proceedings – latest developments and trends in German patent infringement litigation, PharmR 6/2022

In the latest issue of Pharma Recht, Dr Marco Stief and Dr Christian Meyer review and summarise the rather game-changing lega...

9 Jun 2022 -

Patents: New Principles in preliminary injunction proceedings – in: BioScience Law Review, vol. 18 issue 5 (06, 2022)

In her publication "Patents: New Principles in preliminary injunction proceedings",

16 May 2022 -

A quiet but important step for software patents in Germany, 2022

Dr Simon Lud explains in Managing Intellectual Property how a German court judgment is advantageous for patent applications in the fields of artificial intelligence and quantum computing.

26 Apr 2022 -

Haftungsbegrenzungen und Freistellungsvereinbarungen insbesondere in Technologie- und Unternehmenskaufverträgen (M&A), Lizenz- und F&E-Verträgen, 2022

In the second part of the recently published article on contractual IP warranties, Dr Marco Stief discusses (1) limitations and restrictions of liability and (2) contractual indemnification obligations,...

30 Mar 2022 -

Vertragliche IP Garantien in Pharmaverträgen, insbesondere M&A, Lizenz und F&E Verträge, 2022

In the current issue of PharmR, Maiwald partner Dr Marco Stief takes a close-up look at contractual IP warranties, more specifically in the context of contracts regarding M&A, licensing, and researc...

24 Mar 2022 -

Clarification on the transfer of priority rights expected at the EPO, 2022

Dr Matthias Hoffmann discusses in Managing Intellectual Property the uncertainty over the transfer of priority rights and the joint applicants approach at the EPO.

20 Jan 2022 -

USB stick meets sufficiently specific test in Germany, 2022

Dr Christian Meyer discusses in a publication of Managing Intellectual Property a case concerning the domain muenchen.de, in which a reference to a USB stic...

2 Nov 2021 -

2nd Edition of the Handbook “The Supplementary Protection Certificates (SPC)”

We are delighted to announce the release of the 2nd Edition of the Handbook “The Supplementary Protection Certificates (SPC)” edited by our partner Dr. Marco Stief. The book provides a detailed...

2 Nov 2021 -

JUVE Handbook 2021/2022: Co-publishing article on the topic of „Chancen und Stolpersteine bei Videoverhandlungen am EPA“

In the current edition of the JUVE Handbook for Commercial Law Firms 2021/2022 published in October 2021 Dr Eva Ehlich,

28 Oct 2021 -

New referral to the EBoA: post-filed experimental evidence and plausibility, 2021

by Dr Stefanie Parchmann

27 Oct 2021 -

Alignment of Pharmaceutical Strategy for Europe with the Action Plan on IP, 2021

by Dr Gisela Grabow in Managing Intellectual Property

26 Oct 2021 -

Admissibility of non-challenge clauses and pay-for-delay agreements in settlements and license, 2021

by Dr Marco Stief In the current October issue of Pharma Recht - a specialist journal for pharmaceutical law our partner Dr. Marco Stief has written ...

14 Oct 2021 -

Das Versuchs- und Bolar-Privileg im Bereich der mittelbaren Patentverletzung, 2021

by Dr Marco Stief and

1 Sep 2021 -

German Court Calls for Better Enforcement of Preliminary Injunctions in Patent Infringement Case, 2021

by Dr Christian Meyer in Managing Intellectual Property

1 Aug 2021 -

Enlarged Board of Appeal Rules on Double Patenting, 2021

by Dr Annelie Wünsche and Dr Stefanie Parchmann

1 Aug 2021 -

Vertragshandbuch Pharma und Life Sciences, C.H.BECK, 2., erw. Auflage – 2021 (gemeinsam hrsg. mit Boris Bromm)

by Dr Marco Stief and Boris Bromm The current manual offers a comprehensive collection of a...

1 Jun 2021 -

Wir helfen dem Erfinder, seine Idee zu schützen, 2021

by Dr Sophie Ertl in ZEIT „Arbeitswelten der Zukunft“

1 May 2021 -

Patente treiben Innovation und Fortschritt, 2021

by Dr Eva Ehlich and Dr Christian Schäflein in Smart Rechtsguide 2021

1 May 2021 -

Germany: EBA Set to Hear Case on the Legality of the EPO’s Video Proceedings, 2021

by Dr Eva Ehlich and Angela Zumstein

1 May 2021 -

Connected Cars, SEP and Frand-Cjeu Referral With a Focus on Multi-Tier Supply Chains, 2021

by Dr Marco Stief and Heike Röder-Hitschke in Journal of Intellectual Property Law & Practice

1 May 2021 -

CJEU SANTEN: No More SPC protection for new indications and new galenic formulations? (2021)

by Dr Marco Stief and Dr Robert Wenzel in Journal of Intellectual Property Law & Practice

25 Apr 2021 -

EPA: Videoconferencing at the EPO – Springboard Into a Digital Age

1 Apr 2021 -

Videoconferencing at the EPO – Springboard Into a Digital Age?

1 Apr 2021 -

Admissibility of Second Infringement Action Based on the Same Patent, but Different Infringing Act

by Damla Simsek and Dr Stefanie Parchmann

28 Jan 2021 -

The launch of Horizon Europe: The EU initiative for research and innovation, 2021

by Dr Marco Stief in Managing Intellectual Property

7 Jan 2021 -

German court rules against automated dispensing of medicinal products, 2021

by Dr Christian Meyer in Managing Intellectual Property

23 Nov 2020 -

Recent amendments to the SPC Regulation, 2020

by Dr Derk Vos in IAM Innovation & Invention Yearbook: Building IP value in the 21st century This article first appeared in IAM Innovation & Invention Yearbook: Buil...

29 Oct 2020 -

Schutzzertifikat widerrufen, 2020

by Dr Derk Vos in transkript - Life Science Magazine

21 Oct 2020 -

Protection Through Insurance Solutions

by Dr Christian Pisani (together with Rebecca Koch) in Risikomanagement, Organisation, Compliance für Unternehmen Eds. Zenke / Schäfer / Brocke

6 Oct 2020 -

Das Ende von SPCs für neue Indikationen? (2020)

by Dr Marco Stief in the GRUR - Zeitschrift der Deutschen Vereinigung für gewerblichen Rechtsschutz und Urheberrecht

28 Sep 2020 -

Case provides legal certainty for employers and employee inventors, 2020

by Dr Anja Friedrich in Managing Intellectual Property

14 Sep 2020 -

Lieferengpässe in der Arzneimittelindustrie – Ursache, Gründe und Lösungsansätze am Beispiel des Corona Virus (Teil 2), 2020

by Dr Marco Stief and Dr Boris Bromm in Pharma Recht - Fachzeitschrift für das gesamte Arzneimittelrecht

10 Jul 2020 -

Distinguishing Between a Technical Feature and a Representation of Information, 2020

by Stefan Bianchin in Managing Intellectual Property

1 Jul 2020 -

EMA and EU Commission offer flexibility instead of intervention, 2020

by Dr Gisela Grabow in Managing Intellectual Property

16 Jun 2020 -

Lieferengpässe in der Arzneimittelindustrie – Ursache, Gründe und Lösungsansätze am Beispiel des Corona Virus (Teil 1), 2020

by Dr Marco Stief and Dr Boris Bromm in Pharma Recht - Fachzeitschrift für das gesamte Arzneimittelrecht

15 Apr 2020 -

Forum Shopping Is Becoming More Difficult, 2020

by Dr Annelie Wünsche in Managing Intellectual Property

15 Apr 2020 -

How are patents interpreted after nullity proceedings? (2020)

by Thomas Ederer in Managing Intellectual Property

25 Mar 2020 -

Handbuch des Patentrechts, 2. Auflage, 2020

2nd edition 2020 Eds. Haedecke / Timmann, edited i. a. by Dr Dirk Bühler and

31 Jan 2020 -

Rechtliche Probleme des ergänzenden Schutzzertifikats für Arzneimittel, 2020

Using the example of medical indications, excipients and combinations of active ingredients by Dr Marco Stief Publisher Carl Heymanns Verlag I...

26 Nov 2019 -

Compliance Requirements for Effective Risk Management

by Elke Wurster and Dr Christian Pisani in MPJ - Medizinprodukte Journal

26 Nov 2019 -

CJEU Clarifies the Impact of a Declaration

by Stephan Schneller in Managing Intellectual Property

14 Nov 2019 -

Auch “kleinere” Ideen sind schützenswert, 2020

by Dr Eva Dörner and Alexander Ortlieb in Rechtsguide 2020 (insert of Süddeutsche Zeitun...

30 Oct 2019 -

German Federal Patent Court Releases New Decision, 2019

by Stefan Bianchin in Managing Intellectual Property

28 Oct 2019 -

AIPPI Study Question 2019 Plausability

by Dr Ina Bürck in Study Guidelines, 2019 AIPPI Word Congress - London additional authors: Heiko Dumlich, Johannes Gierlich, Robin Keulertz, Simon Klopschinski, Philipp Marchand, Michael Schne...

9 Oct 2019 -

Protection of inventions in AI and digitalisation, 2020

by Dr Christian Schäflein and Dr Fabian Kiendl in IAM Yearbook: Building IP value i...

7 Oct 2019 -

FCJ Clarifies Requirements for Enforcement of Time-Barred and Non-Time-Barred Claims, 2019

by Dr Christian Meyer in Managing Intellectual Property

7 Oct 2019 -

Claim Interpretation If Preamble Equates to State of the Art

by Dr Volker Tegeder in Managing Intellectual Property

26 Aug 2019 -

General Court confirms lack of likelihood of confusion between IOS FINANCE and EOS

by Stephan Schneller and Samira Weik in World Trademark Review This article first appeared on WTR Daily, part of World Trademark Review, in (07/2019). For further information, please go t...

25 Jul 2019 -

Supreme Court Shows Distrust of Digital Deadline Management System, 2019

by Sebastian Herzog in Managing Intellectual Property

4 Jul 2019 -

CAR-T-Zelltherapien – Herausforderungen beim IP, 2019

by Dr Dirk Bühler in BioTechnologie Jahrbuch 2019

24 May 2019 -

What Happens When Prior Art Is Described in a Patent?

by Dr Martin Trautmann in Managing Intellectual Property

17 May 2019 -

Pregabalin and Fulvestrant – a comparison of German and English liability regimes for Swiss-type claims in light of current case law, 2019

by Dr Marco Stief and Ulrike Zorr in Journal of Intellectual Property Law & Practice und GRUR Gewerblicher Rechtsschutz und Urheberrec...

16 May 2019 -

Process patents and the partial outsourcing of individual procedural steps into patent-free foreign countries – opportunity or risk? (2018)

by Marco Stief together with Katja Bolender in Expert Guides

23 Oct 2018 -